Literature DB >> 10805974

Differential expansion and survival of high and low avidity cytotoxic T cell populations during the immune response to a viral infection.

M A Alexander-Miller1.   

Abstract

The importance of high avidity CTL for the effective clearance of viral infections is now well established. Thus one would predict that the preferential activation and expansion of high avidity CTL following viral challenge and retention of these cells in the memory pool would be optimal for the immune response. However, whether this actually occurs during the immune response to viral infection is unknown. In this report I have analyzed the avidity of the CTL specific for the OVA(257-264) peptide during acute infection with a recombinant vaccinia expressing ovalbumin and in the memory population. I have found that the relative ratio of high and low avidity CTL varies over the course of an immune response. Thus CTL avidity is an important factor in the expansion and survival of CTL in vivo. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805974     DOI: 10.1006/cimm.1999.1632

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  9 in total

1.  Altered function in CD8+ T cells following paramyxovirus infection of the respiratory tract.

Authors:  Peter M Gray; Subhashini Arimilli; Ellen M Palmer; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

2.  Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter.

Authors:  R W Tindle; K Herd; T Doan; G Bryson; G R Leggatt; P Lambert; I H Frazer; M Street
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  A novel CD8-independent high-avidity cytotoxic T-lymphocyte response directed against an epitope in the phosphoprotein of the paramyxovirus simian virus 5.

Authors:  P M Gray; G D Parks; M A Alexander-Miller
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity.

Authors:  Elizabeth J Faul; Celestine N Wanjalla; James P McGettigan; Matthias J Schnell
Journal:  Virology       Date:  2008-10-21       Impact factor: 3.616

Review 5.  Tricks with tetramers: how to get the most from multimeric peptide-MHC.

Authors:  Linda Wooldridge; Anna Lissina; David K Cole; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

6.  Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.

Authors:  Robert H Mealey; Baoshan Zhang; Steven R Leib; Matt H Littke; Travis C McGuire
Journal:  Virology       Date:  2003-09-01       Impact factor: 3.616

Review 7.  T cell sensitivity and the outcome of viral infection.

Authors:  L J Walker; A K Sewell; P Klenerman
Journal:  Clin Exp Immunol       Date:  2009-12-01       Impact factor: 4.330

Review 8.  Peptide Dose and/or Structure in Vaccines as a Determinant of T Cell Responses.

Authors:  Graham R Leggatt
Journal:  Vaccines (Basel)       Date:  2014-07-02

9.  CD8αα Expression Marks Terminally Differentiated Human CD8+ T Cells Expanded in Chronic Viral Infection.

Authors:  L J Walker; E Marrinan; M Muenchhoff; J Ferguson; H Kloverpris; H Cheroutre; E Barnes; P Goulder; Paul Klenerman
Journal:  Front Immunol       Date:  2013-08-06       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.